A Pilot Study of MK-3475 With Cryotherapy for Men With Newly Diagnosed Oligo-metastatic Prostate Cancer
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Pembrolizumab (Primary) ; Degarelix
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 21 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 10 Nov 2015 Planned primary completion date changed from 1 Dec 2018 to 1 Nov 2018, according to ClinicalTrials.gov record.